3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The liver is responsible for many metabolic, endocrine and exocrine functions. Approximately 2 million deaths per year are associated with liver failure. Modern 3D bioprinting technologies allied with autologous induced pluripotent stem cells (iPS)-derived grafts could represent a relevant tissue engineering approach to treat end stage liver disease patients. However, protocols that accurately recapitulates liver’s epithelial parenchyma through bioprinting are still underdeveloped. Here we evaluated the impacts of using single cell dispersion (i.e. obtained from conventional bidimensional differentiation) of iPS-derived parenchymal (i.e. hepatocyte-like cells) versus using iPS-derived hepatocyte-like cells spheroids (i.e. three-dimensional cell culture), both in combination with non-parenchymal cells (e.g. mesenchymal and endothelial cells), into final liver tissue functionality. Single cell constructs showed reduced cell survival and hepatic function and unbalanced protein/amino acid metabolism when compared to spheroid printed constructs after 18 days in culture. In addition, single cell printed constructs revealed epithelial-mesenchymal transition, resulting in rapid loss of hepatocyte phenotype. These results indicates the advantage of using spheroid-based bioprinting, contributing to improve current liver bioprinting technology towards future regenerative medicine applications and liver physiology and disease modeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Kuleshov, M. V., Jones, M. R., Rouillard, A. D., Fernandez, N. F., Duan, Q., Wang, Z., Koplev, S., Jenkins, S. L., Jagodnik, K. M., Lachmann, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw377 · Cited by 10,799
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., Santos, A., Doncheva, N. T., Roth, A., Bork, P., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw937 · Cited by 6,980
Markstedt, K., Mantas, A., Tournier, I., Martínez Ávila, H., Hägg, D., & Gatenholm, P. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00188 · Cited by 1,528
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment
Huang, G., Li, F., Zhao, X., Ma, Y., Li, Y., Lin, M., Jin, G., Lu, T. J., Genin, G. M., & Xu, F. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00094 · Cited by 825
Cell and tissue engineering for liver disease
Bhatia, S. N., Underhill, G. H., Zaret, K. S., & Fox, I. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005975 · Cited by 309
Long-term culture and expansion of primary human hepatocytes
Levy, G., Bomze, D., Heinz, S., Ramachandran, S. D., Noerenberg, A., Cohen, M., Shibolet, O., Sklan, E., Braspenning, J., & Nahmias, Y. (2015) · Nature Biotechnology · doi:10.1038/nbt.3377 · Cited by 155
Liver tissue engineering and cell sources: issues and challenges
Palakkan, A. A., Hay, D. C., PR, A. K., TV, K., & Ross, J. A. (2013) · Liver International · doi:10.1111/liv.12134 · Cited by 130
Research works printed but not linked: 39
- Ge, 2016, Treatment of patients with cirrhosis, New Engl. J. Med., 375, 767, 10.1056/NEJMra1504367 · DOI · Paper page
- Goldman, 2016, Human pluripotent stem cells: myths and future realities for liver cell therapy, Cell Stem Cell, 18, 703, 10.1016/j.stem.2016.05.019 · DOI
- Faulkner-Jones, 2015, Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D, Biofabrication, 7, 10.1088/1758-5090/7/4/044102 · DOI · Paper page
- Ma, 2016, Deterministically patterned biomimetic human iPS-derived hepatic model via rapid 3D bioprinting, PNAS, 113, 2206, 10.1073/pnas.1524510113 · DOI · Paper page
- Kizawa, 2017, Scaffold-free 3D bio-printed human liver tissue stably maintains metabolic functions useful for drug discovery, Biochem. Biophys. Rep., 10, 186, 10.1016/j.bbrep.2017.04.004 · DOI · Paper page
- Bishop, 2017, 3D bioprinting technologies in tissue engineering and regenerative medicine: current and future trends, Genes Dis., 4, 185, 10.1016/j.gendis.2017.10.002 · DOI · Paper page
- Lee, 2010, Bio-printing of collagen and VEGF-releasing fibrin gel scaffolds for neural stem cell culture, Exp. Neurol., 223, 645, 10.1016/j.expneurol.2010.02.014 · DOI · Paper page
- Hsieh, 2015, 3D bioprinting: a new insight into the therapeutic strategy of neural tissue regeneration, Organogenesis, 11, 153, 10.1080/15476278.2015.1123360 · DOI
- Ma, 2015, Bioprinting 3D cell-laden hydrogel microarray for screening human periodontal ligament stem cell response to extracellular matrix, Biofabrication, 7, 10.1088/1758-5090/7/4/044105 · DOI · Paper page
- Ma, 2017, Bioprinting-based PDLSC-ECM screening for in vivo repair of alveolar bone defect using cell-laden, injectable and photocrosslinkable hydrogels, ACS Biomater. Sci. Eng., 3, 3534, 10.1021/acsbiomaterials.7b00601 · DOI · Paper page
- Lee, 2014, Design and fabrication of human skin by three-dimensional bioprinting, Tissue Eng. C, 20, 473, 10.1089/ten.tec.2013.0335 · DOI · Paper page
- Ng, 2016, Polyelectrolyte gelatin-chitosan hydrogel optimized for 3D bioprinting in skin tissue engineering, Int. J. Bioprinting, 2, 53, 10.18063/IJB.2016.01.009 · DOI · Paper page
- Ma, 2018, 3D spatiotemporal mechanical microenvironment: a hydrogel-based platform for guiding stem cell fate, Adv. Mater., 30, 10.1002/adma.201705911 · DOI · Paper page
- Pettinato, 2016, Scalable differentiation of human IPSCs in a multicellular spheroid-based 3D culture into hepatocyte-like cells through direct wnt/β-catenin pathway inhibition, Sci. Rep., 6, 32888, 10.1038/srep32888 · DOI
- Meier, 2017, Hepatic differentiation of human IPSCs in different 3D models: a comparative study, Int. J. Mol. Med., 40, 1759, 10.3892/ijmm.2017.3190 · DOI · Paper page
- Kamei, 2019, Three-dimensional cultured liver-on-a-chip with mature hepatocyte-like cells derived from human pluripotent stem cells, Biomed. Microdevices, 21, 73, 10.1007/s10544-019-0423-8 · DOI
- Goulart, 2019, Adult and iPS-derived non-parenchymal cells regulate liver organoid development through differential modulation of Wnt and TGF-β, Stem Cell Res. Ther., 10, 258, 10.1186/s13287-019-1367-x · DOI
- Rashidi, 2018, 3D human liver tissue from pluripotent stem cells displays stable phenotype in vitro and supports compromised liver function in vivo, Arch. Toxicol., 92, 3117, 10.1007/s00204-018-2280-2 · DOI · Paper page
- Carnielli, 2018, Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer, Nat. Commun., 9, 359, 10.1038/s41467-018-05696-2 · DOI · Paper page
- Fabregat, 2018, The reactome pathway knowledgebase, Nucleic Acids Res., 4, D649, 10.1093/nar/gkx1132 · DOI · Paper page
- Mi, 2009, PANTHER pathway: an ontology-based pathway database coupled with data analysis tools, Methods Mol. Biol., 563, 123, 10.1007/978-1-60761-175-2_7 · DOI · Paper page
- Chong, 2018, MetaboAnalyst 4.0: towards more transparent and integrative metabolomics analysis, Nucleic Acids Res., 46, W486, 10.1093/nar/gky310 · DOI · Paper page
- Lyu, 2018, Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system, Stem Cell Res. Ther., 9, 92, 10.1186/s13287-018-0839-8 · DOI
- Ruiz de Galarreta, 2017, Therapeutic editing of hepatocyte genome in vivo, J. Hepatol., 67, 818, 10.1016/j.jhep.2017.05.012 · DOI
- Tang, 2018, The TORC1-regulated CPA complex rewires an RNA processing network to drive autophagy and metabolic reprogramming, Cell Metab., 27, 1040, 10.1016/j.cmet.2018.02.023 · DOI
- Cameron, 2015, Recombinant laminins drive the differentiation and self-organization of hESC-derived hepatocytes, Stem Cell Rep., 5, 1250, 10.1016/j.stemcr.2015.10.016 · DOI · Paper page
- Wang, 2017, Defined and scalable generation of hepatocyte-like cells from human pluripotent stem cells, J. Vis. Exp., 121, 55355, 10.3791/55355 · DOI
- Armstrong, 2016, 3D bioprinting using a templated porous bioink, Adv. Healthcare Mater., 5, 1724, 10.1002/adhm.201600022 · DOI · Paper page
- Kim, 2016, Xeno-sensing activity of the aryl hydrocarbon receptor in human pluripotent stem cell-derived hepatocyte-like cells, Sci. Rep., 6, 21684, 10.1038/srep21684 · DOI
- Husson, 2003, Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle, Eur. J. Biochem., 270, 1887, 10.1046/j.1432-1033.2003.03559.x · DOI · Paper page
- Baiocchini, 2016, Extracellular matrix molecular remodeling in human liver fibrosis evolution, PLoS One, 11, 10.1371/journal.pone.0151736 · DOI · Paper page
- Attallah, 2007, Immunodetection of collagen types I, II, III, and IV for differentiation of liver fibrosis stages in patients with chronic HCV, J. Immunoassay Immunochem., 28, 155, 10.1080/15321810701212088 · DOI
- Xue, 2013, Hepatic regeneration and the epithelial to mesenchymal transition, World J. Gastroenterol., 19, 1380, 10.3748/wjg.v19.i9.1380 · DOI
- Choi, 2009, Epithelial-to-mesenchymal transitions in the liver, Hepatology, 50, 2007, 10.1002/hep.23196 · DOI · Paper page
- Zeisberg, 2007, Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition, J. Biol. Chem., 282, 23337, 10.1074/jbc.M700194200 · DOI · Paper page
- Zhao, 2016, Epithelial-mesenchymal transition in liver fibrosis, Biomed. Rep., 4, 269, 10.3892/br.2016.578 · DOI · Paper page
- Yap, 2013, Enhanced liver progenitor cell survival and differentiation in vivo by spheroid implantation in a vascularized tissue engineering chamber, Biomaterials, 34, 992, 10.1016/j.biomaterials.2013.02.011 · DOI
- Cicchini, 2015, Molecular mechanisms controlling the phenotype and the EMT/MET dynamics of hepatocyte, Liver Int., 35, 302, 10.1111/liv.12577 · DOI · Paper page
- Li, 2017, A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes, Nat. Commun., 3, 15166, 10.1038/ncomms15166 · DOI
Cited by
Fundamentals and Applications of Photo-Cross-Linking in Bioprinting
Lim, K. S., Galarraga, J. H., Cui, X., Lindberg, G. C. J., Burdick, J. A., & Woodfield, T. B. F. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00812 · Cited by 416
A critical perspective on 3D liver models for drug metabolism and toxicology studies
Serras, A. S., Rodrigues, J. S., Cipriano, M., Rodrigues, A. V., Oliveira, N. G., & Miranda, J. P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.626805 · Cited by 138
Olgasi, C., Cucci, A., & Follenzi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176215 · Cited by 100
“Bio compatible ink were used to print iPSC-derived parenchymal and non-parenchymal cells to generate a 3D liver organoid ND 3D liver organoid showed hepatic functions [136]”
Method3D human liver spheroids for translational pharmacology and toxicology
Ingelman‐Sundberg, M., & Lauschke, V. M. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13587 · Cited by 62
Kammerer, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910214 · Cited by 59
Metadata
- Authors
- Goulart, E., de Caires-Junior, L. C., Telles-Silva, K. A., Araujo, B. H. S., Rocco, S. A., Sforca, M., de Sousa, I. L., Kobayashi, G. S., Musso, C. M., Assoni, A. F., Oliveira, D., Caldini, E., Raia, S., Lelkes, P. I., & Zatz, M.
- Venue
- Biofabrication
- Publisher
- IOP Publishing
- Published
- 2019-11-27
- Volume
- 12
- Issue
- 1
- Pages
- 015010
- ISSN
- 1758-5082 (ISSN-L)
- 1758-5090
- OpenAlex
- W2977786572
- Cited by
- 129
- References
- 9
- FWCI
- 6.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- publishingsupport.iopscience.iop.org/iop-standard/v1 (vor)
- iopscience.iop.org/info/page/text-and-data-mining (tdm)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/08028-1)
- INCT Envelhecimento e Doenças Genéticas: Genômica e Metagenômica (2014/50931-3)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro. https://app.cochat.ai/papers/10.1088/1758-5090/ab4a30
- The paper
- Goulart, E., de Caires-Junior, L. C., Telles-Silva, K. A., Araujo, B. H. S., Rocco, S. A., Sforca, M., de Sousa, I. L., Kobayashi, G. S., Musso, C. M., Assoni, A. F., Oliveira, D., Caldini, E., Raia, S., Lelkes, P. I., & Zatz, M. (2020). 3D bioprinting of liver spheroids derived from human induced pluripotent stem cells sustain liver function and viability in vitro. Biofabrication. https://doi.org/10.1088/1758-5090/ab4a30
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.